Market Cap

Paratek Pharmaceuticals, Inc. Market Capitalization:

$125.7 Million

USD as of July 1, 2023

business Paratek Pharmaceuticals, Inc. Company Profile

Paratek Pharmaceuticals, Inc. Main Stock Listing

NASDAQ: PRTK

Market Capitalization History of Paratek Pharmaceuticals, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Paratek Pharmaceuticals, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $129.2 M -47.41%
Jan. 1, 2022 $245.6 M -37.60%
Jan. 1, 2021 $393.6 M 93.15%
Jan. 1, 2020 $203.8 M -50.22%
Jan. 1, 2019 $409.4 M -55.74%
Jan. 1, 2018 $924.9 M 0.99%
Jan. 1, 2017 $915.8 M 3.28%
Jan. 1, 2016 $886.7 M -40.81%
Jan. 1, 2015 $1.50 B -38.00%
Jan. 1, 2014 $2.42 B -43.15%
Jan. 1, 2013 $4.25 B -27.18%
Jan. 1, 2012 $5.84 B -3.37%
Jan. 1, 2011 $6.04 B 8.50%
Jan. 1, 2010 $5.57 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Paratek Pharmaceuticals, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Paratek Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: PRTK

Stock: FSX: N4CN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.